Clinical Trial

Clinical Study of Perioperative Sleep Disorders in Cardiac Surgery

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated February 7, 2025 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this clinical trial is to understand the effects of dexmedetomidine and esketamine on postoperative sleep in patients undergoing cardiac surgery. The main questions it aims to answer are: Does dexmedetomidine or esketamine prevent the development of postoperative sleep disturbances? Which one works better? The researchers compared dexmedetomidine and esketamine with saline (a drug-free solvent) to see if dexmedetomidine and esketamine prevented the development of postoperative sleep disturbances. Participants will: 1. Intraoperative continuous infusion of dexmedetomidine, esketamine or saline until the end of surgery 2. Postoperative sleep was assessed on the first and third postoperative days using a sleep rating scale
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-15.
Status change: Active, Not Recruiting → Recruiting 2025-02-05
Trial Details
NCT Number NCT06778811
Lead Sponsor Nanjing First Hospital, Nanjing Medical University
Conditions Sleep Wake Disorders, Esketamine and the Quality of Recovery, Dexmedetomidine
Enrollment 180 participants
Start Date 2024-10-11
Primary Completion 2025-09 (estimated)
Study Completion 2025-09 (estimated)
Updated on ClinicalTrials.gov 2025-02-07